Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Impact of Primary Ambulatory Thromboprophylaxis (PATP) with Low-Molecular Weight Heparins (LMWHs) on Survival in Patients with Locally Advanced or Metastatic Lung Cancer (LC) Receiving Chemotherapy

Kyaw Zin Thein, MDMBBS, Lukman Tijani, MD, Thein H. Oo, MD

Blood (2019) 134 (Supplement_1): 3466.

https://doi.org/10.1182/blood-2019-128561

Published: 2019

Journal Articles

Updated Meta-Analysis of Randomized Controlled Trials on Primary Ambulatory Thromboprophylaxis (PATP) in Patients with Locally Advanced or Metastatic Lung Cancer Receiving Chemotherapy

Kyaw Zin Thein, MDMBBS, Lukman Tijani, MD, Thein H. Oo, MD

Blood (2019) 134 (Supplement_1): 2435.

https://doi.org/10.1182/blood-2019-123144

Published: 2019

Journal Articles

Effectiveness of Standard-Dose Thromboprophylaxis with Enoxaparin in Preventing Recurrent Venous Thromboembolism in Pregnancy

Marie Claire McLintock, MD, Renee Eslick, MBBS, Stephanie Cox

Blood (2018) 132 (Supplement 1): 3802.

https://doi.org/10.1182/blood-2018-99-119405

Published: 2018

Journal Articles

Low- Molecular Weight Heparins (LMWH) Versus Vitamin K Antagonists (VKAs) in the Treatment and Secondary Prevention of Cancer-Associated Venous Thromboembolism (VTE): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

Kyaw Zin Thein, MD MBBS, Lukman Tijani, MD, Thein H. Oo, MD FACP, FRCP

Blood (2016) 128 (22): 1180.

https://doi.org/10.1182/blood.V128.22.1180.1180

Published: 2016

Journal Articles

Risk of Bleeding from Primary Thromboprophylaxis (PTP) in Patients with Solid Cancer Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT)

Kyaw Zin Thein, MD MBBS, Aung M Tun, MD, Sai-Ching J Yeung, MD PhD FACP, Thein H. Oo, MD FACP, FRCP

Blood (2016) 128 (22): 3820.

https://doi.org/10.1182/blood.V128.22.3820.3820

Published: 2016

Journal Articles

A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT) in Ambulatory Thromboprophylaxis (ATP) in Patients with Lung Cancer Receiving Chemotherapy

Kyaw Zin Thein, MD MBBS, Sai-Ching J Yeung, MD PhD FACP, Thein H. Oo, MD FACP, FRCP

Blood (2016) 128 (22): 3825.

https://doi.org/10.1182/blood.V128.22.3825.3825

Published: 2016

Journal Articles

The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study

Adi J. Klil-Drori, MD, Janie Coulombe, MSc, Sharon J. Nessim, MD MSc, Vicky Tagalakis, MD MSc

Blood (2016) 128 (22): 89.

https://doi.org/10.1182/blood.V128.22.89.89

Published: 2016

Journal Articles

Management of Perioperative Anticoagulation in Patients with VWD

Mario Von Depka, MD PhD, Carsten Detering, MSc, Stefanie Döpke, Mahnaz Ekhlasi-Hundrieser, PhD

Blood (2015) 126 (23): 1100.

https://doi.org/10.1182/blood.V126.23.1100.1100

Published: 2015

Journal Articles

Heparin Re-Exposure in Patients with Heparin-Induced Thrombocytopenia (HIT)

Prajwal Dhakal, M.B.B.S, Vijaya R. Bhatt, MBBS

Blood (2014) 124 (21): 4265.

https://doi.org/10.1182/blood.V124.21.4265.4265

Published: 2014

Journal Articles

Benefit and Risk of Primary Thromboprophylaxis in Ambulatory Patients with Advanced Pancreatic Cancer Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Nay Min Tun, MD, Elizabeth Guevara, MD, Thein H. Oo, MD FACP, FRCP

Blood (2014) 124 (21): 4266.

https://doi.org/10.1182/blood.V124.21.4266.4266

Published: 2014

Journal Articles

Hypercoagulability Promotes Atrial Fibrosis and Fibrillation

Henri M.H. Spronk, PhD, Anne-Margreet de Jong, MD PhD, Hetty C. de Boer, PhD, Alexander Maas, MD, Sander Verheule, PhD, Michiel Rienstra, MD PhD, Pieter W. Kamphuisen, MD PhD, Hugo ten Cate, Harry J Crijns, MD PhD, Isabelle van Gelder, MD PhD, Anton Jan van Zonneveld, PhD, Ullrich Schotten, MD PhD

Blood (2014) 124 (21): 4246.

https://doi.org/10.1182/blood.V124.21.4246.4246

Published: 2014

Journal Articles

Low Molecular Weight Heparin Modulates Thrombin Generation in Cancer Patients Undergoing Antithrombotic Therapy for Overt Venous Thromboembolism

Anna Falanga, MD, Carmen J Tartari, PhD, Marina R Marchetti, PhD, Laura Russo, MBioSc, Kim WFM Lambregts, Davide Resta, MD, Andrea D'Alessio, MD

Blood (2014) 124 (21): 1539.

https://doi.org/10.1182/blood.V124.21.1539.1539

Published: 2014

Journal Articles

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

Dominique Farge, PhD MD, Norbert Claude Gorin, MD PhD, Philippe Debourdeau, MD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 1545.

https://doi.org/10.1182/blood.V124.21.1545.1545

Published: 2014

Journal Articles

Heparin Does Not Increase Live Births in Pregnant Women with Previous Unexplained Recurrent Miscarriages: A Systematic Review and Meta-Analysis

Murtadha K. Al-Khabori, MD, MSc, FRCPC, Zainab S. Al-Hosni, Hajer M. Al Ghaithi, Altaf M. Al Maamari, Wafa S. Bessiso, Khalil Al Farsi, BSc MD, ABIM, FRCPC, Mohammed Al-Huneini, MD, FRCPC, Arwa Z. Al-Riyami, MD, BSc, Shahina Daar

Blood (2012) 120 (21): 504.

https://doi.org/10.1182/blood.V120.21.504.504

Published: 2012

Journal Articles

Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial

Ida Martinelli, Piero Ruggenenti, Irene Cetin, Giorgio Pardi, Annalisa Perna, Patrizia Vergani, Barbara Acaia, Fabio Facchinetti, Giovanni Battista La Sala, Maddalena Bozzo, Stefania Rampello, Luca Marozio, Olimpia Diadei, Giulia Gherardi, Sergio Carminati, Giuseppe Remuzzi, Pier Mannuccio Mannucci

Blood (2012) 119 (14): 3269–3275.

https://doi.org/10.1182/blood-2011-11-391383

Published: 2012

Includes: Supplemental data

Journal Articles

Cancer Patients Requiring Interruption of Long-Term Anticoagulant Therapy: The Use of Fixed Sub-Therapeutic Doses of Low-Molecular Weight Heparin

Giorgia Saccullo, Alessandra Malato, Lucio Lo Coco, Ilenia Barbello, Clementina Caracciolo, Simona Raso, Marco Santoro, Orazio Graziano Di Bartolo, Ambra Di Piazza, Vincenzo Abbadessa, Sergio Siragusa, MD

Blood (2011) 118 (21): 1244.

https://doi.org/10.1182/blood.V118.21.1244.1244

Published: 2011

Journal Articles

Outpatient Treatment In Patients with Acute Pulmonary Embolism: The Hestia Study

Wendy Zondag, MD, Inge Mos, MD, Dina Creemers, MD, Lidia Hoogerbrugge, MD, Olaf Dekkers, MD, PhD, Anneke Dolsma, MD, Michiel Eijsvogel, MD, Laura Faber, MD, PhD, Herman MA Hofstee, MD, Marcel Hovens, MD, PhD, Ge Jonkers, MD, Klaas Kralingen, MD, PhD, Marieke Kruip, MD, PhD, Tom Vlasveld, MD, PhD, Marielle Vreede, MD, Menno Huisman, MD, PhD

Blood (2010) 116 (21): LBA-1.

https://doi.org/10.1182/blood.V116.21.LBA-1.LBA-1

Published: 2010

Journal Articles

Bleeding Complications of Fondaparinux Versus Nadroparine in Knee Replacement Surgery Patients.

Margriet Dijkstra, Jr., MD, Carina LE Gerritsma, Sr., MD, PhD, Jos JAM van Raay, Sr., MD, PhD, Inge van den Akker Scheek, PhD, Marinus van Hulst, Sr., PhD

Blood (2009) 114 (22): 3127.

https://doi.org/10.1182/blood.V114.22.3127.3127

Published: 2009

Journal Articles

Thrombin Generation Assessment in Platelet Rich Plasma Offers Additional Criteria for Low Molecular Weight Heparin Antithrombotic Fingerprint Characterization.

Grigorios T. Gerotziafas, Dr, Galea Vasso, Dr, Jeanine M. Walenga, PhD, Evi Kalodiki, Dr, Mourad Chaari, Dr, Hatmi Mohamed, Dr, Jawed Fareed, Elalamy Ismail, Pr

Blood (2009) 114 (22): 4177.

https://doi.org/10.1182/blood.V114.22.4177.4177

Published: 2009

Journal Articles

Aspirin and Aspirin Combined with Low-Molecular-Weight Heparin in Women with Unexplained Recurrent Miscarriage: a Randomized Controlled Multicenter Trial (ALIFE Study).

Stef P. Kaandorp, MD, Mariëtte Goddijn, MD, PhD, Joris A.M. van der Post, MD, PhD, Barbara A. Hutten, PhD, Harold R. Verhoeve, MD, Karly Hamulyak, MD, PhD, Ben-Willem Mol, MD, PhD, Nienke Folkeringa, MD, PhD, Marleen Nahuis, MD, Dimitri Papatsonis, MD, PhD, Harry R. Buller, MD, PhD, Fulco van der Veen, MD, PhD, Saskia Middeldorp, MD, PhD

Blood (2009) 114 (22): 488.

https://doi.org/10.1182/blood.V114.22.488.488

Published: 2009

NARROW

Impact of Primary Ambulatory Thromboprophylaxis (PATP) with Low-Molecular Weight Heparins (LMWHs) on Survival in Patients with Locally Advanced or Metastatic Lung Cancer (LC) Receiving Chemotherapy

Updated Meta-Analysis of Randomized Controlled Trials on Primary Ambulatory Thromboprophylaxis (PATP) in Patients with Locally Advanced or Metastatic Lung Cancer Receiving Chemotherapy

Effectiveness of Standard-Dose Thromboprophylaxis with Enoxaparin in Preventing Recurrent Venous Thromboembolism in Pregnancy

Low- Molecular Weight Heparins (LMWH) Versus Vitamin K Antagonists (VKAs) in the Treatment and Secondary Prevention of Cancer-Associated Venous Thromboembolism (VTE): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

Risk of Bleeding from Primary Thromboprophylaxis (PTP) in Patients with Solid Cancer Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT)

A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT) in Ambulatory Thromboprophylaxis (ATP) in Patients with Lung Cancer Receiving Chemotherapy

The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study

Management of Perioperative Anticoagulation in Patients with VWD

Heparin Re-Exposure in Patients with Heparin-Induced Thrombocytopenia (HIT)

Benefit and Risk of Primary Thromboprophylaxis in Ambulatory Patients with Advanced Pancreatic Cancer Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Hypercoagulability Promotes Atrial Fibrosis and Fibrillation

Low Molecular Weight Heparin Modulates Thrombin Generation in Cancer Patients Undergoing Antithrombotic Therapy for Overt Venous Thromboembolism

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

Heparin Does Not Increase Live Births in Pregnant Women with Previous Unexplained Recurrent Miscarriages: A Systematic Review and Meta-Analysis

Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial

Cancer Patients Requiring Interruption of Long-Term Anticoagulant Therapy: The Use of Fixed Sub-Therapeutic Doses of Low-Molecular Weight Heparin

Outpatient Treatment In Patients with Acute Pulmonary Embolism: The Hestia Study

Bleeding Complications of Fondaparinux Versus Nadroparine in Knee Replacement Surgery Patients.

Thrombin Generation Assessment in Platelet Rich Plasma Offers Additional Criteria for Low Molecular Weight Heparin Antithrombotic Fingerprint Characterization.

Aspirin and Aspirin Combined with Low-Molecular-Weight Heparin in Women with Unexplained Recurrent Miscarriage: a Randomized Controlled Multicenter Trial (ALIFE Study).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only